Should I buy Lear (LEA) stock or is it too late?

Lear · Consumer Discretionary · price $120

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 61% of its targets hit on this sector (220 calls tested). It aims for $132 (+10 %), call made on October 8, 2026, maturing on October 8, 2027 (6 d ago).

The 3 reliable analysts $138+15 %

The 5 other firms $150+25 %

How to read it: the 3 reliable firms are not filtered by optimism — 3 aim above the price, 0 below, hence their $138 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Lear

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
UBS	86 %	+34.5 %	7	$132 +10%
Citigroup	70 %	+9.6 %	10	$179 +50%
Morgan Stanley	47 %	+5.0 %	19	$123 +3%
RBC Capital	60 %	+3.6 %	5	$139 +16%
B of A Securities	44 %	+1.3 %	9	$123 +3%
JP Morgan	38 %	-3.2 %	8	$150 +25%
Wells Fargo	22 %	-8.0 %	9	$138 +15%
Goldman Sachs	12 %	-11.9 %	8	$124 +4%

In short — Should you invest in Lear? Is it too late, still worth it? Analysts are split (25% buy, median target $142, i.e. +19%), and the most reliable on LEA targets even higher. But the stock is volatile. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $142, i.e. +19% from the current price ($120).
The most reliable firm on LEA, UBS (86% hit rate, 7 scored calls), targets $132 (call made on October 7, 2026, maturing on October 7, 2027) (+10%) in its most recent call, and $135 (call made on January 14, 2026, maturing on January 14, 2027) (+13%) in the one coming due soonest.
Pays a dividend (2.4% yield) — regular income on top of potential upside.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 8 ratings, 6 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.

The analyst consensus on LEA

Median target $142 (+19%) · 8 ratings · Hold consensus

Strong Buy00%

Buy225%

Hold675%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Lear now?

We won't decide for you. The facts: 25% of analysts rate it a buy, median target $142 (+19%), and UBS (most reliable on LEA, 86%) targets $132. Weigh that against valuation and volatility. This is not personalized advice.

Is it too late to invest in Lear?

Not according to analysts: the median target ($142) is still +19% above the current price ($120) (most reliable on LEA: UBS, 86%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Lear still worth investing in?

It depends on the gap between the price ($120) and its estimated value: analysts target $142 on median (+19%), with 25% buys (most reliable on LEA: UBS, 86%). Cross-check with their real reliability on LEA and the cautions above. Information, not advice.

What's the main risk in buying LEA?

The consensus is not unanimous: of 8 ratings, 6 are neutral.

→ Go deeper: the full Lear profile (consensus, analyst reliability, price target, performance).